FDA 510(k) Applications for Medical Device Product Code "NYI"
(Classifier, Prognostic, Recurrence Risk Assessment, Rna Gene Expression, Breast Cancer)

FDA 510(k) Number Applicant Device Name Decision Date
K101454 AGENDIA MAMMAPRINT 01/28/2011
K141142 AGENDIA MAMMAPRINT FFPE 01/23/2015
K081092 AGENDIA MODIFICATION TO MAMMAPRINT 12/11/2009
DEN070009 AGENDIA BV MAMMAPRINT 02/06/2007
K070675 AGENDIA BV MAMMAPRINT 06/22/2007
K080252 AGENDIA BV MODIFICATION TO MAMMAPRINT 07/21/2008
K201902 Agendia Inc. MammaPrint 11/05/2020
K210973 Agendia Inc. MammaPrint FFPE NGS Kit 09/08/2022
K130010 NANOSTRING TECHNOLOGIES PROSIGNA(TM) BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY 09/06/2013
K141771 NANOSTRING TECHNOLOGIES INC. PROSIGNA BREAST CANCER PROGNOSTIC GENE SIGNATURE ASSAY 11/07/2014


Search | Companies | Product Codes | Device Names | Contacts | Applications | Decisions | Contact